These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25939882)

  • 1. Sphingosine 1-phosphate signaling at the blood-brain barrier.
    Prager B; Spampinato SF; Ransohoff RM
    Trends Mol Med; 2015 Jun; 21(6):354-63. PubMed ID: 25939882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
    Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM
    PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
    Front Immunol; 2018; 9():2189. PubMed ID: 30319641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
    Schuhmann MK; Bittner S; Meuth SG; Kleinschnitz C; Fluri F
    Int J Mol Sci; 2015 Dec; 16(12):29454-66. PubMed ID: 26690412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature].
    Shmyrev VI; Kryzhanovskiĭ SM; Danilycheva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):93-7. PubMed ID: 22677684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Sphingosine-1-Phosphate Receptor 4 Regulates Blood-Brain Barrier Permeability and Promotes a Homeostatic Endothelial Phenotype.
    Hansen L; Lohfink N; Vutukuri R; Kestner RI; Trautmann S; Hecht M; Wagner PV; Spitzer D; Khel MI; Macas J; Ferreirós N; Gurke R; Günther S; Pfeilschifter W; Devraj K
    J Neurosci; 2022 Mar; 42(10):1908-1929. PubMed ID: 34903569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial S1P
    Nitzsche A; Poittevin M; Benarab A; Bonnin P; Faraco G; Uchida H; Favre J; Garcia-Bonilla L; Garcia MCL; Léger PL; Thérond P; Mathivet T; Autret G; Baudrie V; Couty L; Kono M; Chevallier A; Niazi H; Tharaux PL; Chun J; Schwab SR; Eichmann A; Tavitian B; Proia RL; Charriaut-Marlangue C; Sanchez T; Kubis N; Henrion D; Iadecola C; Hla T; Camerer E
    Circ Res; 2021 Feb; 128(3):363-382. PubMed ID: 33301355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
    Nishihara H; Shimizu F; Sano Y; Takeshita Y; Maeda T; Abe M; Koga M; Kanda T
    PLoS One; 2015; 10(3):e0121488. PubMed ID: 25774903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
    Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
    Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.
    Leo A; Citraro R; Marra R; Palma E; Paola EDD; Constanti A; De Sarro G; Russo E
    CNS Neurol Disord Drug Targets; 2017; 16(3):311-325. PubMed ID: 27823573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption.
    Vutukuri R; Brunkhorst R; Kestner RI; Hansen L; Bouzas NF; Pfeilschifter J; Devraj K; Pfeilschifter W
    J Neurochem; 2018 Jan; 144(2):172-185. PubMed ID: 29023711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
    Garris CS; Wu L; Acharya S; Arac A; Blaho VA; Huang Y; Moon BS; Axtell RC; Ho PP; Steinberg GK; Lewis DB; Sobel RA; Han DK; Steinman L; Snyder MP; Hla T; Han MH
    Nat Immunol; 2013 Nov; 14(11):1166-72. PubMed ID: 24076635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
    Tsai HC; Han MH
    Drugs; 2016 Jul; 76(11):1067-79. PubMed ID: 27318702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate in coagulation and inflammation.
    Obinata H; Hla T
    Semin Immunopathol; 2012 Jan; 34(1):73-91. PubMed ID: 21805322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P
    Stepanovska Tanturovska B; Zivkovic A; Imeri F; Homann T; Kleuser B; Stark H; Huwiler A
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second generation S1P pathway modulators: research strategies and clinical developments.
    Bigaud M; Guerini D; Billich A; Bassilana F; Brinkmann V
    Biochim Biophys Acta; 2014 May; 1841(5):745-58. PubMed ID: 24239768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators.
    Soliven B; Miron V; Chun J
    Neurology; 2011 Feb; 76(8 Suppl 3):S9-14. PubMed ID: 21339490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
    Hamidi Shishavan M; Bidadkosh A; Yazdani S; Lambooy S; van den Born J; Buikema H; Henning RH; Deelman LE
    PLoS One; 2016; 11(9):e0162029. PubMed ID: 27583547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.
    Blaho VA; Galvani S; Engelbrecht E; Liu C; Swendeman SL; Kono M; Proia RL; Steinman L; Han MH; Hla T
    Nature; 2015 Jul; 523(7560):342-6. PubMed ID: 26053123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.